$0.82
3.24% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US44148G1058
Symbol
HOTH
Sector
Industry

Hoth Therapeutics, Inc. Stock price

$0.82
-0.07 7.72% 1M
-0.34 29.47% 6M
-0.62 43.19% YTD
-0.21 20.57% 1Y
-24.68 96.79% 3Y
-107.68 99.25% 5Y
-212.43 99.62% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.03 3.24%
ISIN
US44148G1058
Symbol
HOTH
Sector
Industry

Key metrics

Market capitalization $5.65m
Enterprise Value $-2.34m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.29
P/B ratio (TTM) P/B ratio 0.75
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-7.53m
Free Cash Flow (TTM) Free Cash Flow $-8.02m
Cash position $8.02m
EPS (TTM) EPS $-1.40
P/E forward negative
Short interest 9.04%
Show more

Is Hoth Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Hoth Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Hoth Therapeutics, Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Hoth Therapeutics, Inc. forecast:

Buy
100%

Financial data from Hoth Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.69 4.69
101% 101%
-
- Research and Development Expense 2.84 2.84
48% 48%
-
-7.53 -7.53
32% 32%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -7.53 -7.53
32% 32%
-
Net Profit -7.51 -7.51
34% 34%
-

In millions USD.

Don't miss a Thing! We will send you all news about Hoth Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hoth Therapeutics, Inc. Stock News

Neutral
PRNewsWire
17 days ago
NEW YORK , Oct. 29, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company dedicated to developing new generation therapies for unmet medical needs, is excited to announce highly promising early data from a preclinical study of its latest cancer treatment. The preliminary results demonstrate that the treatment successfully stabilizes tumor growth...
Neutral
PRNewsWire
about one month ago
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative treatments, is proud to announce the granting of a U.S. patent for its pioneering Alzheimer's treatment, HT-ALZ. This milestone patent secures the company's intellectual property rights to its novel therapeutic approach, as Hoth accelerates...
Neutral
PRNewsWire
about 2 months ago
Early observations suggest that the vehicle-treated Alzheimer's mice exhibit a larger population of reactive astrocytes, while the HT-ALZ treated groups show fewer reactive astrocytes, pointing to a potential breakthrough in the treatment of Alzheimer's. NEW YORK, Sept.
More Hoth Therapeutics, Inc. News

Company Profile

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.

Head office United States
CEO Robbie Knie
Employees 6
Founded 2017
Website www.hoththerapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today